Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-27 2:22 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | Logos Global Management LP | 5,000,000 7.800% | 5,000,000 (New Position) | View |
| 2024-11-14 7:13 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Logos Global Management LP | 5,078,927 4.900% | 1,609,000 (+46.37%) | View |
| 2024-11-14 7:05 pm Sale | 13G | Elevation Oncology Inc. ELEV | Logos Global Management LP | 3,500,000 5.900% | -150,000 (-4.11%) | View |
| 2024-11-14 6:59 pm Purchase | 13G | NEXTCURE INC NXTC | Logos Global Management LP | 2,500,000 8.900% | 499,540 (+24.97%) | View |
| 2024-11-14 6:55 pm Sale | 13G | CYBIN INC. CYBN | Logos Global Management LP | 0 0.000% | -40,000,000 (Position Closed) | View |
| 2024-11-14 6:51 pm Sale | 13G | aTYR PHARMA INC ATYR | Logos Global Management LP | 1,750,000 2.100% | -4,050,000 (-69.83%) | View |
| 2024-11-14 6:46 pm Sale | 13G | Annexon Inc. ANNX | Logos Global Management LP | 2,900,000 2.700% | -4,044,444 (-58.24%) | View |
| 2024-11-14 6:40 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Logos Global Management LP | 416,666 2.000% | 416,666 (New Position) | View |
| 2024-10-23 6:09 pm Purchase | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Logos Global Management LP | 100,000 2.200% | 100,000 (New Position) | View |
| 2024-08-27 5:22 pm Purchase | 13G | CYBIN INC. CYBN | Logos Global Management LP | 40,000,000 5.300% | 40,000,000 (New Position) | View |
| 2024-08-13 6:53 pm Purchase | 13D | Design Therapeutics Inc. DSGN | Logos Global Management LP | 4,232,627 7.500% | 1,420,126 (+50.49%) | View |
| 2024-06-06 6:49 pm Sale | 13D | Olema Pharmaceuticals Inc. OLMA | Logos Global Management LP | 3,248,818 5.800% | -1,018,130 (-23.86%) | View |
| 2024-04-01 6:34 pm Purchase | 13G | NEXTCURE INC NXTC | Logos Global Management LP | 2,000,460 7.200% | 2,000,460 (New Position) | View |
| 2024-02-22 3:47 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Logos Global Management LP | 15,000,000 7.200% | 15,000,000 (New Position) | View |
| 2024-02-14 4:01 pm Sale | 13G | Allakos Inc. ALLK | Logos Global Management LP | 2,900,000 3.300% | -2,386,666 (-45.15%) | View |
| 2024-02-14 3:51 pm Purchase | 13G | SPYRE THERAPEUTICS, INC SYRE | Logos Global Management LP | 150,000 0.400% | 150,000 (New Position) | View |
| 2024-02-13 7:31 pm Sale | 13G | IDEAYA Biosciences Inc. IDYA | Logos Global Management LP | 1,800,000 2.800% | -2,100,000 (-53.85%) | View |
| 2024-02-13 7:23 pm Purchase | 13G | Annexon Inc. ANNX | Logos Global Management LP | 6,944,444 8.300% | 3,844,444 (+124.01%) | View |
| 2024-01-22 4:57 pm Purchase | 13G | Elevation Oncology Inc. ELEV | Logos Global Management LP | 3,650,000 8.600% | 3,650,000 (New Position) | View |
| 2024-01-22 4:27 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Logos Global Management LP | 3,469,927 9.900% | 3,469,927 (New Position) | View |